| Announced on | Meeting on |
| May 13, 2024 | May 20, 2024 |
| Audited Results | |
| Jan 30, 2024 | Feb 07, 2024 |
| Quarterly Results & Others | |
| Nov 01, 2023 | Nov 09, 2023 |
| Quarterly Results | |
| Jul 26, 2023 | Aug 03, 2023 |
| Quarterly Results | |
| May 11, 2023 | May 18, 2023 |
| Audited Results | |
Ajooni Biotech Share Price
NSE
- Open6.50
- High6.77
- Low6.48
- Prev Close6.46
- Volume58,38,064
- VWAP(₹)6.71
Ajooni Biotech Ltd. share price insights
Employee & Interest Expense
Company has spent less than 1% of its operating revenues towards interest expenses and 2.25% towards employee cost in the year ending 31 Mar, 2024. (Source: Standalone Financials)Stock Returns vs Nifty Smallcap 100
Stock gave a 3 year return of -37.27% as compared to Nifty Smallcap 100 which gave a return of 80.38%. (as of last trading session)Ajooni Biotech Ltd. Share Price Update
Ajooni Biotech Ltd. share price moved up by 4.49% from its previous close of Rs 6.46. Ajooni Biotech Ltd. stock last traded price is 6.75
Share Price Value Today/Current/Last 6.75 Previous Day 6.46
Ajooni Biotech Ltd. Share Price Returns
| 1 Day | 4.49% |
| 1 Month | 14.41% |
| 3 Months | 11.57% |
| 1 Year | 42.11% |
| 3 Years | -43.09% |
| 5 Years | N.A. |
Key Metrics
| PE Ratio(x) | 27.36 |
| EPS - TTM(₹) | 0.25 |
| MCap(₹ Cr.) | 59.14 |
| MCap Rank | 15 |
| PB Ratio(x) | 1.33 |
| Div Yield(%) | 0.00 |
| Face Value(₹) | 2.00 |
| 52W High(₹) | 6.98 |
| 52W Low(₹) | 4.42 |
| MCap/Sales | 0.65 |
| Beta(1 Month) | -0.02 |
| BV/Share(₹) | 4.87 |
Ajooni Biotech Share Recommendations
No Recommendations details available for this stock.
Check out other stock recos.
ADVERTISEMENT
ADVERTISEMENT
Ajooni Biotech Financials
Consolidated
Mar 2024 Dec 2023 Sep 2023 Jun 2023 Mar 2023 Total Income 19.84 21.62 19.77 21.07 41.52 Total Income Growth (%) -8.26 9.38 -6.19 -49.24 289.80 Total Expenses 18.23 20.92 19.06 20.55 40.55 Total Expenses Growth (%) -12.86 9.78 -7.25 -49.33 289.20 EBIT 1.61 0.70 0.71 0.53 0.97 EBIT Growth (%) 128.67 -1.29 34.96 -45.37 316.86 Profit after Tax (PAT) 0.91 0.44 0.40 0.40 0.54 PAT Growth (%) 108.00 8.67 0.70 -25.46 398.80 EBIT Margin (%) 8.11 3.25 3.60 2.51 2.33 Net Profit Margin (%) 4.61 2.03 2.05 1.91 1.30 Basic EPS (₹) 0.10 0.25 0.23 0.23 0.31 All figures in Rs Cr, unless mentioned otherwise
InsightsEmployee & Interest Expense
Company has spent less than 1% of its operating revenues towards interest expenses and 2.25% towards employee cost in the year ending 31 Mar, 2024. (Source: Standalone Financials)
Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 Total Assets 47.52 58.73 29.02 28.03 23.07 Total Assets Growth (%) -19.09 102.38 3.53 21.50 26.41 Total Liabilities 4.81 17.06 12.64 12.38 7.18 Total Liabilities Growth (%) -71.81 34.97 2.10 72.42 17.90 Total Equity 42.71 41.67 16.38 15.65 15.89 Total Equity Growth (%) 2.50 154.40 4.66 -1.51 30.67 Current Ratio (x) 10.74 2.28 2.18 2.05 3.00 Total Debt to Equity (x) 0.05 0.12 0.33 0.43 0.32 Contingent Liabilities 0.00 - - - - All figures in Rs Cr, unless mentioned otherwise
Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 Net Cash flow from Operating Activities -3.95 -5.58 3.68 1.16 -4.38 Net Cash used in Investing Activities 7.64 -15.82 -1.90 -3.41 0.47 Net Cash flow from Financing Activities -3.57 21.66 -1.97 2.37 3.30 Net Cash Flow 0.12 0.25 -0.19 0.12 -0.61 Closing Cash & Cash Equivalent 0.43 0.31 0.06 0.24 0.12 Closing Cash & Cash Equivalent Growth (%) 38.40 439.16 -76.49 97.03 -83.05 Total Debt/ CFO (x) -0.55 -0.93 1.45 5.87 -1.15 All figures in Rs Cr, unless mentioned otherwise
Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 Return on Equity (%) 5.06 2.69 6.40 2.38 2.18 Return on Capital Employed (%) 7.98 4.72 10.55 6.20 4.69 Return on Assets (%) 4.54 1.91 3.61 1.33 1.50 Interest Coverage Ratio (x) 7.95 6.40 5.76 1.86 2.47 Asset Turnover Ratio (x) 1.51 1.70 2.60 182.11 173.54 Price to Earnings (x) 23.98 30.86 64.52 81.97 18.45 Price to Book (x) 1.21 0.83 4.11 1.94 0.40 EV/EBITDA (x) 12.07 12.90 23.34 22.19 8.68 EBITDA Margin (%) 5.52 4.10 4.20 3.26 3.24
ADVERTISEMENT
Peer Comparison
NAME 1D 1W 1M 3M 1Y 3Y 5Y Ajooni Biotech Ltd. Stock Performance 4.49 10.66 3.05 14.41 43.62 -37.27 0.00 Godrej Agrovet Stock Performance -1.06 52.07 42.26 53.15 80.29 42.30 55.85 Narmada Agrobase Stock Performance 4.95 18.07 28.69 5.17 25.46 0.00 0.00 All values in %
Insights
Stock Returns vs Nifty Smallcap 100
Stock gave a 3 year return of -37.27% as compared to Nifty Smallcap 100 which gave a return of 80.38%. (as of last trading session)
Mutual Funds Ownership
No Data Available
ADVERTISEMENT
Corporate Actions
Board Meeting
Audited Results
May 13, 2024
Board Meeting
Quarterly Results & Others
Jan 30, 2024
Board Meeting
Quarterly Results
Nov 01, 2023
No Data Available
Announced on Ex-Date Jan 23, 2021 Mar 10, 2021 Bonus Ratio: 1 share(s) for every 9 shares held Announced on Ex-Date Aug 25, 2022 Oct 07, 2022 Split: Old FV10.0| New FV:2.0 Announced on Ex-Date Oct 14, 2023 May 07, 2024 Rights ratio: 1 share for every 1 held at a price of Rs 5.0 Aug 02, 2021 Nov 25, 2022 Rights ratio: 29 share for every 30 held at a price of Rs 6.0 Announced on Meeting on Jul 19, 2023 Sep 05, 2023 Annual General Meeting Sep 04, 2018 Sep 28, 2018 Book closure from 22 Sep, 2018 to 28 Sep, 2018
ADVERTISEMENT
About
Ajooni Biotech Ltd., incorporated in the year 2010, is a Small Cap company (having a market cap of Rs 116.26 Crore) operating in Agriculture/Horticulture/Livestock sector.
Ajooni Biotech Ltd. key Products/Revenue Segments include Cattle Feed for the year ending 31-Mar-2023.
For the quarter ended 31-03-2024, the company has reported a Standalone Total Income of Rs 19.84 Crore, down 8.26 % from last quarter Total Income of Rs 21.62 Crore and down 52.22 % from last year same quarter Total Income of Rs 41.52 Crore. Company has reported net profit after tax of Rs .91 Crore in latest quarter.
The company’s top management includes Mr.Jasjot Singh, Mr.Jasjot Singh, Mr.Gursimran Singh, Mr.Imteshwar Singh, Mr.Ramandeep Singh, Ms.Simmi Chabbra, Mr.Partek Singh, Mrs.Swati Vijan. Company has Harjeet Parvesh & Company as its auditors. As on 31-03-2024, the company has a total of 8.76 Crore shares outstanding.
About Ajooni Biotech
Ajooni Biotech Ltd., incorporated in the year 2010, is a Small Cap company (having a market cap of Rs 116.26 Crore) operating in Agriculture/Horticulture/Livestock sector. Ajooni Biotech Ltd. key Products/Revenue Segments include Cattle Feed for the year ending 31-Mar-2023.For the quarter ended 31-03-2024, the company has reported a Standalone Total Income of Rs 19.84 Crore, down 8.26 % from last quarter Total Income of Rs 21.62 Crore and down 52.22 % from last year same quarter Total Income of Rs 41.52 Crore. Company has reported net profit after tax of Rs .91 Crore in latest quarter.The company’s top management includes Mr.Jasjot Singh, Mr.Jasjot Singh, Mr.Gursimran Singh, Mr.Imteshwar Singh, Mr.Ramandeep Singh, Ms.Simmi Chabbra, Mr.Partek Singh, Mrs.Swati Vijan. Company has Harjeet Parvesh & Company as its auditors. As on 31-03-2024, the company has a total of 8.76 Crore shares outstanding.
Industry
Key Indices Listed On
-
Address
D-118, Industrial Area,Phase - VII,Mohali, Punjab - 160055
Executive Leadership
JS
Jasjot Singh
Managing DirectorJS
Jasjot Singh
CEO & CFOGS
Gursimran Singh
Whole Time DirectorIS
Imteshwar Singh
Independent DirectorShow More
Auditors
Harjeet Parvesh & Company
FAQs about Ajooni Biotech share
- 1. What's the Ajooni Biotech Ltd. share price today?Ajooni Biotech Ltd. share price was Rs 6.75 as on 05 Jul, 2024, 03:59 PM IST. Ajooni Biotech Ltd. share price was up by 4.49% based on previous share price of Rs. 6.7. In last 1 Month, Ajooni Biotech Ltd. share price moved up by 14.41%.
- 2. What are the returns for Ajooni Biotech Ltd. share?Return Performance of Ajooni Biotech Ltd. Shares:
- 1 Week: Ajooni Biotech Ltd. share price moved up by 28.33%
- 1 Month: Ajooni Biotech Ltd. share price moved up by 14.41%
- 3 Month: Ajooni Biotech Ltd. share price moved up by 11.57%
- 6 Month: Ajooni Biotech Ltd. share price moved down by 2.88%
- 3. What are the key metrics to analyse Ajooni Biotech Ltd. Share Price?Ajooni Biotech Ltd. share can be quickly analyzed on following metrics:
- Stock's PE is 27.36
- Price to Book Ratio of 1.33
- 4. Who are peers to compare Ajooni Biotech Ltd. share price?Top 2 Peers for Ajooni Biotech Ltd. are Narmada Agrobase Ltd. and Godrej Agrovet Ltd.
- 5. What are the Ajooni Biotech Ltd. quarterly results?Total Revenue and Earning for Ajooni Biotech Ltd. for the year ending 2024-03-31 was Rs 82.31 Cr and Rs 2.16 Cr on Standalone basis. Last Quarter 2024-03-31, Ajooni Biotech Ltd. reported an income of Rs 19.84 Cr and profit of Rs 0.91 Cr.
- 6. What is the CAGR of Ajooni Biotech Ltd.?The CAGR of Ajooni Biotech Ltd. is 11.93.
- 7. Who is the CEO of Ajooni Biotech Ltd.?Jasjot Singh is the CEO & CFO of Ajooni Biotech Ltd.
- 8. Who's the owner of Ajooni Biotech Ltd.?Following are the key changes to Ajooni Biotech Ltd. shareholding:
- Promoter holding have gone down from 30.28 (30 Jun 2023) to 26.44 (31 Mar 2024)
- Other investor holding has gone up from 69.72 (30 Jun 2023) to 73.56 (31 Mar 2024)
- 9. What is the market cap of Ajooni Biotech Ltd.?Within the Agriculture/Horticulture/Livestock sector, Ajooni Biotech Ltd. stock has a market cap rank of 15. Ajooni Biotech Ltd. has a market cap of Rs 59.14 Cr.
- 10. What has been highest price of Ajooni Biotech Ltd. share in last 52 weeks?Ajooni Biotech Ltd. share price saw a 52 week high of Rs 6.98 and 52 week low of Rs 4.42.
- 11. What is the PE & PB ratio of Ajooni Biotech Ltd.?The PE ratio of Ajooni Biotech Ltd. stands at 27.04, while the PB ratio is 1.37.
Trending in Markets
DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).
DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.
By using this site, you agree to the Terms of Service and Privacy Policy.